Jeffrey D Bloss

Summary

Affiliation: Eli Lilly and Company
Country: USA

Publications

  1. ncbi request reprint Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma-a Gynecologic Oncology Group Study
    Jeffrey D Bloss
    Department of Obstetrics and Gynecology, Ellis Fischel Cancer Center, University of Missouri Health Sciences Center, Columbia, MO 65203, USA
    Gynecol Oncol 89:148-54. 2003
  2. ncbi request reprint Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study
    Jeffrey D Bloss
    Division of Gynecologic Oncology, Ellis Fischel Cancer Center, University of Missouri Health Sciences Center, Columbia, USA
    J Clin Oncol 20:1832-7. 2002
  3. ncbi request reprint Treatment of ovarian cancer: new strategies
    Philip J Disaia
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Irvine, College of Medicine, Orange, CA 92868 3298, USA
    Gynecol Oncol 90:S24-32. 2003
  4. ncbi request reprint Gemcitabine in cervical cancer
    David G Mutch
    Department of Gynecologic Oncology, Washington University School of Medicine, St Louis, MO 63110, USA
    Gynecol Oncol 90:S8-15. 2003
  5. ncbi request reprint A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study
    Henry M Keys
    Department of Radiation Oncology, Albany Medical College, Albany, NY 12208, USA
    Gynecol Oncol 92:744-51. 2004

Collaborators

Detail Information

Publications5

  1. ncbi request reprint Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma-a Gynecologic Oncology Group Study
    Jeffrey D Bloss
    Department of Obstetrics and Gynecology, Ellis Fischel Cancer Center, University of Missouri Health Sciences Center, Columbia, MO 65203, USA
    Gynecol Oncol 89:148-54. 2003
    ....
  2. ncbi request reprint Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study
    Jeffrey D Bloss
    Division of Gynecologic Oncology, Ellis Fischel Cancer Center, University of Missouri Health Sciences Center, Columbia, USA
    J Clin Oncol 20:1832-7. 2002
    ..This study prospectively evaluates the combination of bleomycin to this regimen in women with histologically proven advanced recurrent or persistent squamous cell carcinoma of the cervix...
  3. ncbi request reprint Treatment of ovarian cancer: new strategies
    Philip J Disaia
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Irvine, College of Medicine, Orange, CA 92868 3298, USA
    Gynecol Oncol 90:S24-32. 2003
    ..The objective was to review the progress made in gene- and molecular-based management of ovarian cancer over the past decade and the future direction of targeted therapies...
  4. ncbi request reprint Gemcitabine in cervical cancer
    David G Mutch
    Department of Gynecologic Oncology, Washington University School of Medicine, St Louis, MO 63110, USA
    Gynecol Oncol 90:S8-15. 2003
    ..The broad clinical effectiveness and low toxicity of gemcitabine in other human malignancies suggest that it might be useful in treating cervical tumors...
  5. ncbi request reprint A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study
    Henry M Keys
    Department of Radiation Oncology, Albany Medical College, Albany, NY 12208, USA
    Gynecol Oncol 92:744-51. 2004
    ....